Jane Street’s Apogee Therapeutics APGE Stock Holding History

Jane Street’s Portfolio APGE Stock Details APGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$431K	Buy	+3,245	New	+$292K	﹤0.01%	8381
2026 Q1	–	Sell	-12,192	Closed	-$885K	–	11496
2025 Q4	$920K	Sell	12,192 -65,434	-84%	-$4.12M	﹤0.01%	6292
2025 Q3	$3.08M	Buy	77,626 +69,391	+843%	+$2.65M	﹤0.01%	4173
2025 Q2	$358K	Sell	8,235 -5,507	-40%	-$209K	﹤0.01%	7529
2025 Q1	$513K	Buy	13,742 +8,174	+147%	+$316K	﹤0.01%	6810
2024 Q4	$252K	Sell	5,568 -12,807	-70%	-$653K	﹤0.01%	8022
2024 Q3	$1.08M	Sell	18,375 -55,518	-75%	-$2.66M	﹤0.01%	5733
2024 Q2	$2.91M	Buy	73,893 +17,714	+32%	+$860K	﹤0.01%	3861
2024 Q1	$3.73M	Buy	56,179 +42,776	+319%	+$1.87M	﹤0.01%	3064
2023 Q4	$374K	Sell	13,403 -6,938	-34%	-$139K	﹤0.01%	7277
2023 Q3	$433K	Buy	+20,341	New	+$448K	﹤0.01%	6503

Other funds holding APGE

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

Jane Street's APGE Position: Q2 2026 in Review

Jane Street opened a new position in Apogee Therapeutics (APGE) in Q2 2026: 3,245 shares worth $431K. The stake represents ﹤0.01% of the portfolio and ranks #8381 among its holdings. This is a return to the name: Jane Street previously reported a position in APGE as recently as Q4 2025.

Jane Street first reported a position in APGE in Q3 2023 and has held it in 11 quarters since. The position peaked at $3.73M in Q1 2024. 289 funds tracked by Wall St. Rank hold APGE as of Q2 2026.

Jane Street held 3,245 shares of Apogee Therapeutics worth $431K as of Q2 2026.
Apogee Therapeutics was a new Jane Street position in Q2 2026.
Apogee Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #8381 holding.
Jane Street first reported a position in Apogee Therapeutics in Q3 2023 and has held it in 11 quarters since.
Jane Street's Apogee Therapeutics position peaked at $3.73M in Q1 2024.
289 funds tracked by Wall St. Rank held Apogee Therapeutics as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.